Researchers from the City of Hope demonstrated that some patients with Type I diabetes can be cured, at least temporarily, with a stem cell transplant. The team’s work was published in Frontiers in Immunology.
The trial enrolled 21 patients and found that autologous hematopoietic stem cell transplantation increased C-peptide levels and induced insulin independence in patients with Type I diabetes. The team concluded that transplanted stem cells are able to “balance” the immune system.
Get the full story at our sister site, Drug Delivery Business News.